logo
Arsenal target Leroy Sané as they close in on Martin Zubimendi

Arsenal target Leroy Sané as they close in on Martin Zubimendi

Times28-05-2025

Arsenal are showing strong interest in Leroy Sané as they close in on completing a deal for Martín Zubimendi.
Mikel Arteta, the Arsenal manager, worked with Sané, 29, at Manchester City and wants to target a winger this summer. Bayern Munich have been in talks with Sané, who is out of contract at the German club this month and has attracted interest from several teams. Sané's agent was due to meet Bayern on Wednesday.
Sane scored 13 goals and claimed six assists across competitions this season, and ten and 13 respectively in the previous campaign. He joined Bayern from City in 2020.
Arsenal have long pursued Nico Williams as their main left-wing target and met the Athletic Bilbao player's representatives in April. Although Williams has a £42million release clause, he is expected to want a wage of more than £250,000 a week. The 22-year-old scored 11 and made seven goals across competitions this season, helping Bilbao to the Europa League semi-finals.
Arsenal want to give Zubimendi, 26, a medical before he joins up with Spain for the Nations League semi-final against France a week tomorrow (June 5). The club have tracked the Real Sociedad midfielder for a couple of seasons. He changed his mind on joining Liverpool last summer after they had been told he was willing to leave his boyhood club.
Arsenal have been in talks about paying instalments rather than meeting his release clause of €60million (about £51million) and paying the money in one instalment, which would have an impact on their transfer kitty this summer.
Zubimendi came through Real Sociedad's academy and has made more than 200 appearances since his debut in 2019. His 15 caps for Spain include featuring against England in the Euro 2024 final. His potential arrival as a holding midfielder could allow Declan Rice to move back to a No8 position alongside captain Martin Odegaard.
Arsenal have been in talks to extend Thomas Partey's contract beyond June and hope to offload a number of fringe players. Nuno Tavares will join Lazio for about £7.9million due to a clause in his loan contract. Fábio Vieira, Albert Sambi Lokonga, Reiss Nelson, Jakub Kiwior and Oleksandr Zinchenko have been made available. The futures of Leandro Trossard and Gabriel Martinelli are unclear.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

English court bars jailed Russian tycoon from appealing in Transneft case
English court bars jailed Russian tycoon from appealing in Transneft case

Reuters

time31 minutes ago

  • Reuters

English court bars jailed Russian tycoon from appealing in Transneft case

MOSCOW, June 5 (Reuters) - The English Court of Appeal has refused jailed Russian tycoon Ziyavudin Magomedov permission to appeal against a decision that threw out his $14 billion lawsuit against Russian oil pipeline monopoly Transneft and other firms, the company said. Magomedov sued the company and several others at London's High Court, alleging his 2018 arrest on embezzlement charges prompted a Russian state-supported scheme to strip him of his holdings in valuable port operators. In January, Transneft, as well as U.S. private equity firm TPG (TPG.O), opens new tab and other companies, won their bid to block Magomedov's London lawsuit. Transneft said late on Wednesday that the English Court of Appeal denied Magomedov permission to appeal the ruling. "It is clear from the English process that there are massive losses which Mr Magomedov has suffered as a result of wrongdoing against him. He will continue to seek justice and a fair outcome wherever he can," a spokesperson for Magomedov said. Magomedov once controlled an empire ranging from port logistics to oil and gas through his Summa Group conglomerate, which he founded with his brother Magomed. But the brothers were arrested on embezzlement and organised crime charges in one of the most high-profile prosecutions of its kind in years. Magomedov was sentenced to 19 years in jail in 2022. He says the charges against him are unfounded and unsuccessfully appealed against his conviction.

Dr Martens returns to growth as bootmaker pledges to stamp out costs
Dr Martens returns to growth as bootmaker pledges to stamp out costs

Daily Mail​

time31 minutes ago

  • Daily Mail​

Dr Martens returns to growth as bootmaker pledges to stamp out costs

Dr Martens shares soared more than 20 per cent on Thursday after the iconic bootmaker revealed it expects to return to profit this year. The retailer, which has struggled for momentum over the last two years, outlined plans to cut costs and scale back discounting in its key markets, including the US and Europe. Dr Martens revealed an annual profit slump as sales came under pressure and it cautioned over ongoing falling revenues in Britain. The footwear group reported pre-tax profits of £8.8million for the year to 30 March, down from £93million the previous year, after seeing sales fall 10 per cent. On an underlying basis, the group's pre-tax profits fell sharply to £34.1million from £97.2million. The company said sales to consumers in the US returned to growth in the second half of the year and had continued to increase, but revealed revenues had remained lower since the year-end 'due to a challenging market'. It added that unfavourable foreign exchange rates would see it take a hit to group sales and profits of around £18million and £3million respectively this year. However, Dr Martens said it expects its underlying profit to rise 'significantly' over the financial year ahead, with analysts expecting a jump to between £54million and £74million. Dr Martens shares rose 21.77 per cent or 13.05p to 73.00p on Thursday, having fallen over 13 per cent in the last year. On curbing discounts, the group said: 'As we look forward into FY26, we will reduce discounting in Americas and EMEA, across both our own ecommerce channel and through wholesale, with the aim of driving full price sales.' The group flagged uncertainty over the impact of higher tariffs, but said it was holding off from price rises for the the remainder of 2025. Its stock is already in the US market for the spring and summer season and either there or on its way for the autumn and winter months. Dr Martens said: 'We do however recognise that there is continued macroeconomic uncertainty and the full outcome of tariffs is still unknown, and we will monitor this closely through the year and take action as appropriate.' The Northamptonshire-based company outlined new plans for growth alongside its results, with aims to attract new shoppers and hold off from discounts in EMEA and the Americas. Annual figures showed sales sales fell 11.4 per cent over the year, although retail lifted 1 per cent in the final six months of the period. In the Europe, Middle East and Africa (EMEA) region, sales fell 11 per cent, with direct-to-consumer difficulty amid a highly promotional market, particularly in Britain, the group said. The company, whose yellow-stitched boots have been a retro mainstay for decades, has been in the doldrums in recent years, with declining revenues exacerbated by the cost-of-living crisis. It listed on the London Stock Exchange in 2021, and has since issued a slew of profit warnings and replaced its chief executive. Many of Dr Martens' recent problems have come from steep declines in sales in the US, but new chief executive Ije Nwokorie said the group had stabilised in the past year. He said: 'Our single focus in 2024-25 was to bring stability back to Dr Martens. 'We have achieved this by returning our direct-to-consumer channel in the Americas back to growth, resetting our marketing approach to focus relentlessly on our products, delivering cost savings and significantly strengthening our balance sheet.' Nwokorie, previously the firm's head of marketing before taking on the top job from Kenny Wilson on 6 January, said: 'I am laser-focused on day-to-day execution, managing costs and maintaining our operational discipline while we navigate the current macroeconomic uncertainties.' Russ Mould, investment director at AJ Bell, said: 'Dr Martens is on the front foot with a strategy that seeks to kick out the troubles of old and return the business to profitable growth. 'This should shift the market's focus from earlier problems in the US and a sharp drop in earnings to a business intent on regaining its power. 'Having a plan is a good start, but the proof will be in the execution. It has laid out ambitions to get back on top. Turning those dreams into reality might not be easy. 'Fundamentally, it's all down to marketing and product innovation. Dr Martens needs to convince the consumer they need its products – get that right, and it could reclaim its crown in the footwear market. 'The brand still has considerable strength, the business just needs to be more creative at the front end and agile at the back end.'

Cristiano Ronaldo shrugs off pre-match scuffle with pitch invader to secure win against Germany
Cristiano Ronaldo shrugs off pre-match scuffle with pitch invader to secure win against Germany

The Independent

time32 minutes ago

  • The Independent

Cristiano Ronaldo shrugs off pre-match scuffle with pitch invader to secure win against Germany

Cristiano Ronaldo scored the winning goal in Portugal 's 2-1 semi-final victory over Germany in Munich, securing their place in the Nations League final. Florian Wirtz initially put Germany ahead in the second half, but Portugal responded with goals from Francisco Conceicao and Ronaldo. Conceicao's goal was a curling effort from 25 yards, while Ronaldo's was a tap-in after a pass from Nuno Mendes. The match was briefly delayed due to an electrical storm, and Ronaldo had a pre-match encounter with a fan seeking a selfie. Portugal will now face either Spain or France in the Nations League final on Sunday.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store